Check-Cap (NSDQ:CHEK) today released interim results from the post-CE Mark approval study of its C-Scan system version 3, touting the device’s ability to detect polyps in un-prepped colons.
Check-Cap touts interim post-CE Mark C-Scan study results
By Michael Tattory|
2018-09-10T17:08:54-04:00
September 4th, 2018|News|Comments Off on Check-Cap touts interim post-CE Mark C-Scan study results